<DOC>
	<DOC>NCT02138838</DOC>
	<brief_summary>This is a phase 3, 24-week, randomized, multicenter, open-label, controlled study. subjects will be randomized into one of two treatment arms; oral administration of cinacalcet daily in addition to standard of care treatment arm or a standard of care arm. Randomization will be stratified by age group. All subjects receive standard of care which can include therapy with Vitamin D sterols, calcium supplementation, and phosphate binders.</brief_summary>
	<brief_title>A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism, Secondary</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Age 6 &lt; 18 years Diagnosis of SHPT with the mean of the two consecutive central laboratory iPTH values ≥ 300 pg/mL during screening Corrected calcium value of ≥ 8.8 mg/dL during screening Diagnosis of CKD, receiving either hemodialysis or peritoneal dialysis, for ≥ 30 days prior to screening Parent or legally acceptable representative has provided written informed consent and subject has provided written assent when required by institutional guidelines History of congenital long QT syndrome, second or third degree heart block, ventricular tachyarrhythmias or other conditions associated with prolonged QT interval Corrected QT interval (QTc) &gt; 500 ms, using Bazett's formula QTc ≥ 450 to ≤ 500 ms, using Bazett's formula, unless written permission to enroll is provided by the investigator after consultation with a pediatric cardiologist Use of grapefruit juice, herbal medications, or potent CYP 3A4 inhibitors (eg, erythromycin, clarithromycin, ketoconazole, itraconazole) Use of concomitant medications that may prolong the QTc interval (eg, ondansetron, albuterol)</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic Kidney Disease, Secondary Hyperparathyroidism, Dialysis, Pediatric</keyword>
</DOC>